|
Sign In to gain access to subscriptions and/or personal tools.
|
Pgp 9.5 and Cyclin D1 Co-Expression in Cutaneous Squamous Cell Carcinomas
Aikaterini Mastoraki*,
Eleftherios Ioannidis,
Aikaterini Apostolaki,
Efstratios Patsouris,
and
Kiriaki Aroni
* To whom correspondence should be addressed. E-mail: dr_kamast{at}yahoo.gr.
 |
Abstract |
|---|
Background: squamous cell carcinoma (SCC) consists of altered keratinocytes, presents variable differentiation, inexorably progresses, and on occasion metastasizes. Objective: to investigate the biological activity of epidermal cells in SCCs by estimating the expression of PGP 9.5 and cyclin D1 using immunohistochemistry. Methods: the sample included 13 well-differentiated cases of cutaneous SCC (grade I), 12 moderately differentiated tumors (grade II), and 7 poorly differentiated lesions (grade III). Four cases belonged to the distinct entity of pseudoadenoid SCC. Results: PGP 9.5 expression was positively correlated with tumor stage (P < .001) and potential perineural invasion (P < .001), whereas cyclin D1 expression correlated inversely with the degree of cellular differentiation (P < .001) and PGP 9.5 immunostaining (P < .001). Conclusion: PGP 9.5 and cyclin D1 coexpression was closely associated with tumor aggressiveness and can be classified as a marker for predicting the outcome of resection-treated skin cancer patients.
First published on May 14, 2009 International Journal of Surgical Pathology 2009, doi:10.1177/1066896909336018

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|